Caplin Point Laboratories has informed that the Board of Directors of the Company at their meeting held today (November 05, 2020) considered and approved the Un-audited Financial Results for the quarter/ half year ended September 30, 2020. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosed Un-audited Financial Results (Consolidated and Standalone) for the quarter/ half year ended September 30, 2020; Limited Review Report (Consolidated and Standalone) for Un-audited Financial Results; Press Release on the above Un-audited Financial Results; and Investors Presentation.
The above information is a part of company’s filings submitted to BSE.
